Investor Relations (IR) Questions: Fibrocell Science FCSC
Click here to return to the biotech IRQ Index
Answers received: February 2013
1) When is the last time FCSC raised cash through an offering (diluted)?
October 12, 2012: $45 million straight common shares
2) How much cash (not cash equivalents) does FCSC have?
At Sept. 30, 2012, essentially nil
3) What and approximately when is the next known catalyst?
Start of clinical programs in pharmaceutical indications
4) What is FCSC's quarterly cash burn?
Approx. $4-4.5 million quarterly
5) Does FCSC have an existing line of credit and if so how much can they draw against it?
No
1) When is the last time FCSC raised cash through an offering (diluted)?
October 12, 2012: $45 million straight common shares
2) How much cash (not cash equivalents) does FCSC have?
At Sept. 30, 2012, essentially nil
3) What and approximately when is the next known catalyst?
Start of clinical programs in pharmaceutical indications
4) What is FCSC's quarterly cash burn?
Approx. $4-4.5 million quarterly
5) Does FCSC have an existing line of credit and if so how much can they draw against it?
No
